Skip to main content
Clinical Trials/ISRCTN12748453
ISRCTN12748453
Active, not recruiting
未知

Increasing access to CBT for psychosis patients: a randomized controlled trial evaluating brief, targeted CBT for distressing voices delivered by Assistant Psychologists

Sussex Partnership NHS Foundation Trust0 sites130 target enrollmentSeptember 28, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Psychosis - schizophrenia
Sponsor
Sussex Partnership NHS Foundation Trust
Enrollment
130
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37715255/ (added 18/09/2023)

Registry
who.int
Start Date
September 28, 2022
End Date
October 29, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. In contact with Secondary Care Mental Health Services (under the care of a mental health team in one of the recruiting Trusts)
  • 2\. Have a clinician\-reported diagnosis of psychosis
  • 3\. Aged 18 yeras or over
  • 4\. Willing to provide written, informed consent
  • 5\. Experiencing current voice\-hearing; this will be operationalised by participants having a score of at least 1 on item 1 (‘Frequently’) on the Psychotic Symptoms Rating Scale \- Auditory Hallucinations Scale (PSYRATS\-AH) at the time of consent – indicating that the participant has experienced at least one episode of voice\-hearing in the past week
  • 6\. Scoring 3 or 4 (rated on a 0–4 scale) on either the intensity of distress item or the amount of distress item on PSYRATS\-AH at the time of consent.

Exclusion Criteria

  • 1\. Established organic cause for distressing voices
  • 2\. Primary diagnosis of substance misuse
  • 3\. Currently detained in hospital under a section of the Mental Health Act
  • 4\. Having completed a full course (minimum of 16 hours) of CBTp for psychotic symptoms during the past year
  • 5\. Immediate and serious risk to self or others (assessed at the point of referral/eligibility review).

Outcomes

Primary Outcomes

Not specified

Similar Trials